Hydrochloric Acid → 4-[3-(4-{3-Trifluoromethylphenyl}piperazinyl)propylthio]pyrimidine
反応式
[SH:1][C:2]1[CH:7]=[CH:6][N:5]=[CH:4][N:3]=1.Cl[CH2:9][CH2:10][CH2:11][N:12]1[CH2:17][CH2:16][N:15]([C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([C:24]([F:27])([F:26])[F:25])[CH:19]=2)[CH2:14][CH2:13]1.C(N(CC)CC)C.Cl>CN(C=O)C>[F:27][C:24]([F:25])([F:26])[C:20]1[CH:19]=[C:18]([N:15]2[CH2:14][CH2:13][N:12]([CH2:11][CH2:10][CH2:9][S:1][C:2]3[CH:7]=[CH:6][N:5]=[CH:4][N:3]=3)[CH2:17][CH2:16]2)[CH:23]=[CH:22][CH:21]=1参加物
6
実験手順
1.5 g (13.4 mmol) of 4-mercaptopyrimidine, 4.3 g (14 mmol) of 1-(3-chloropropyl)-4-(3-trifluoromethylphenyl)piperazine and 1.5 g (15 mmol) of triethylamine in 5 ml of DMF were stirred at 100° C. for 1 hour. The mixture was then poured into 5% strength hydrochloric acid and extracted with MTB ether. The aqueous phase was made alkaline with sodium hydroxide solution and then extracted with ethyl acetate, and the organic phase was dried over MgSO4 and concentrated. The residue was purified by chromatography (mobile phase: CH2Cl2/CH3OH=98/2). 3.0 g of product were obtained as a yellowish oil (=59% yield).
後処理
- extractionextracted with MTB ether
- extractionextracted with ethyl acetate
- dry with materialthe organic phase was dried over MgSO4
- concentrationconcentrated
- customThe residue was purified by chromatography (mobile phase: CH2Cl2/CH3OH=98/2)
出典と根拠
- ORDレコード
- ord-dcf0e05e74a84555a2f58dbd17d8d5f0
- 出典データセット
- uspto-grants-2002_09
- 特許番号
- US06444674B1
反応ノート
読み込み中…